RecruitingNCT01386437
Rare condition
Aspergillosis
26
studies recruiting now
as of 7 Sept 2026
272
studies registered in total
as of 7 Sept 2026
3
countries with a recruiting site
as of 7 Sept 2026
20 Jul 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT07714863
ML-Based ABPA Recurrence Prediction and Clinical Utility
RecruitingNCT07690345
Fungal Status and Prognosis in ABPA
RecruitingNCT07681583
Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor Score
RecruitingNCT07611838
Multi-Omics Inflammatory Phenotype for ABPA Recurrence Risk Prediction
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 26 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Aspergillosis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Aspergillosis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
8 approved treatments and 11 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: CaspofunginApproved: Amphotericin B (Abelcet)Approved: Isavuconazole (Cresemba)Approved: Isavuconazonium Sulfate (Cresemba)Approved: Itraconazole (Fungitraxx)Approved: Caspofungin Acetate (Cancidas)Approved: Voriconazole (Vfend)Approved: Posaconazole (Noxafil)
Phase 3Amcipatricin Diascorbate
Phase 3Anidulafungin (Ecalta)
Phase 3Olorofim
Phase 3Micafungin Sodium (Fungard)
Phase 3Ibrexafungerp
Phase 3Pyrrole
Phase 3Fluconazole (Canesten oral)
Phase 2Opelconazole
+ 3 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).